Key Developments: Procter & Gamble Co (PG)

PG on New York Consolidated

81.76USD
17 Apr 2014
Price Change (% chg)

$0.11 (+0.13%)
Prev Close
$81.65
Open
$81.47
Day's High
$81.89
Day's Low
$81.34
Volume
8,374,713
Avg. Vol
9,813,015
52-wk High
$85.82
52-wk Low
$73.61

Search Stocks

Latest Key Developments (Source: Significant Developments)

Mars Inc to buy Procter & Gamble Co's pet food business
Wednesday, 9 Apr 2014 09:00am EDT 

Procter & Gamble Co and Mars Inc:Says Mars has agreed to buy the IAMS, EUKANUBA, and NATURA brands in major markets for $2.9 Billion in cash.The companies expect to complete the transaction in the second-half of 2014.  Full Article

Procter & Gamble Co declares a 7pct dividend increase
Monday, 7 Apr 2014 07:00am EDT 

Procter & Gamble Co:Declares increase in the quarterly dividend from $0.6015 to $0.6436 per share on its Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the company.Payable on or after May 15, to Common Stock shareholders of record at the close of business on April 25 and to Series A and Series B Preferred Stock shareholders of record at the start of business on April 25.  Full Article

Procter & Gamble Co updates FY 2014 guidance
Tuesday, 11 Feb 2014 04:10pm EST 

Procter & Gamble Co:Updates outlook for fiscal 2014 all-in and core EPS growth following recent policy announcements by the Venezuelan government that impact foreign exchange rates applied to various transactions as well as significant exchange rate movements in Argentina and other developing countries.Lowers guidance for all-in sales and all-in earnings growth to reflect the increased impact from foreign exchange.Confirms prior outlook for organic sales growth and currency-neutral earnings per share growth.Confirms outlook for organic sales growth of 3 pct. to 4 pct. for fiscal 2014.Expects foreign exchange to reduce sales growth by 2 pct. to 3 pct., which results in an adjusted guidance range for all-in sales growth of in-line to up 2 pct. versus the prior year.Adjusts guidance range for core earnings per share (EPS) growth to 3 pct. to 5 pct., from a previous range of 5 pct. to 7 pct., to reflect the impact of Venezuela and other foreign exchange rate changes.Expects on an all-in GAAP basis, diluted earnings per share to increase 2 pct. to 5 pct. versus the prior fiscal year.Reported revenue of $84.167 bln and EPS of $4.05 in fiscal 2013.Fiscal 2014 revenue of $85.299 bln and EPS of $4.25 - Thomson Reuters I/B/E/S.  Full Article

Procter & Gamble Co reaffirms FY 2014 guidance
Friday, 24 Jan 2014 07:00am EST 

Procter & Gamble Co:Reaffirmed FY 2014 guidance.Expects FY 2014 organic sales growth of 3 pct to 4 pct.Expects FY 2014 core EPS to grow 5 pct to 7 pct.Says it reported revenue of $84.2 bln and EPS of $3.86 in FY 2013.FY 2014 Revenue of $85.812 bln and EPS of $4.27 - Thomson Reuters I/B/E/S.  Full Article

Procter & Gamble Co declares quarterly dividend
Tuesday, 14 Jan 2014 01:00pm EST 

Procter & Gamble Co:Says it has declared a quarterly dividend of $0.6015 per share on the Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock of the company.Says it will be payable on or after Feb. 18, to Common Stock shareholders of record at the close of business on Jan. 24, and to Series A and Series B Preferred Stock shareholders of record at the start of business on Jan. 24.  Full Article

Procter & Gamble Co to develop $100 mln plant in 2014-Reuters
Thursday, 5 Dec 2013 08:45pm EST 

Procter & Gamble Co:Plans to develop its second factory worth $100 million in Karawang next year, said P&G vice chairman Dimitri Panayotopoulos-Reuters.The firm expects the facility to start operation in 2017.  Full Article

Procter & Gamble Co Reaffirms FY 2014 Guidance - Conference Call
Tuesday, 19 Nov 2013 08:35am EST 

Procter & Gamble Co announced that for fiscal 2014, it is maintaining organic sales growth guidance range of 3% to 4% and core earnings per share (EPS) growth remains at 5% to 7%. This translates to constant currency core earnings per share growth in the range of 11% to 13% and on an all-in GAAP basis, earnings per share to grow approximately 7% to 9%. The Company reported revenue of $84.2 billion and EPS of $3.86 in fiscal 2013. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $86 billion for fiscal 2014.  Full Article

Isonea Ltd Signs Agreement With Procter & Gamble Co's TREMOR To Promote AirSonea To Women
Tuesday, 29 Oct 2013 09:00pm EDT 

Isonea Ltd announced that it has signed an agreement with TREMOR, a division of Procter & Gamble (P&G), aiming to promote AirSonea to women with asthma and mothers of children with asthma.  Full Article

Procter & Gamble Co Reiterates FY 2014 Guidance
Friday, 25 Oct 2013 07:00am EDT 

Procter & Gamble Co reiterated its fiscal 2014 guidance and expect organic sales growth of 3% to 4%. All-in sales growth is estimated in the range of 1% to 2%, including a negative foreign exchange impact of approximately 2%. Core earnings per share (EPS) are expected to grow 5% to 7% for fiscal 2014 , and reported EPS are expected to grow in the range of 7% to 9%. Also, the Company noted that it expects the second quarter negative earnings impact from foreign exchange to be similar to what it was in the first quarter. The Company reported revenue of $84.2 billion and EPS of $3.86 in fiscal 2013. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $86 billion for fiscal 2014.  Full Article

Procter & Gamble Co Issues FY 2014 Guidance
Thursday, 1 Aug 2013 07:00am EDT 

Procter & Gamble Co announced that for fiscal 2014, it expects organic sales growth in the range of 3% to 4% compared to underlying global market growth of about 3.5%. All-in sales growth is forecast in the range of 1%-2%, including a negative foreign exchange impact of approximately 2%. Core earnings per share are expected to grow in the range of 5% to 7%, equal to fiscal 2013 growth at the low end of the range and within the Company's long-term, annual growth objectives at the high end of the range. P&G noted that EPS growth estimates include a six percentage point negative impact from foreign exchange. Reported earnings per share are expected to grow in the range of 7% to 9%, reflecting somewhat lower non-core restructuring costs in fiscal year 2014 versus the prior year. The Company reported revenue of $84.2 billion and EPS of $3.86 in fiscal 2012. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $86 billion and EPS of $4.32 for fiscal 2014.  Full Article

Premium pet food company Freshpet taps banks for IPO: sources

- Freshpet LLC, maker of a healthy variety of cat and dog food, has selected Goldman Sachs Group Inc and Credit Suisse Group AG to lead an initial public offering by the end of the year, two people familiar with the matter said on Wednesday.

Search Stocks